Voyageur Pharmaceuticals's total assets for Q1 2025 were C$3.16M, an increase of 21.52% from the previous quarter. VYYRF total liabilities were C$1.97M for the fiscal quarter, a -8.25% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.